Covid-19: Bharat Biotech's Covaxin, Serum Institute's Covishield vaccines get 'Conditional Market Authorization' approval form DCGI - details here!
DCGI on Thursday gave its nod for market authorization of two COVID-19 vaccines - Covaxin and Covishield subject to certain conditions. Consent came after the the Subject Expert Committee of CDSCO recommended for upgradation of status for vaccines from restricted use in emergency situations to grant of new drug permission
'Conditional Market Authorization' is a new category of market authorization that has emerged during the current global pandemic of COVID19